Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Short term Debt (2019 - 2023)

Historic Short term Debt for Healthequity (HQY) over the last 5 years, with Q1 2023 value amounting to $17.5 million.

  • Healthequity's Short term Debt rose 10000.0% to $17.5 million in Q1 2023 from the same period last year, while for Jan 2023 it was $17.5 million, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $17.5 million for FY2023, which is 10000.0% up from last year.
  • Latest data reveals that Healthequity reported Short term Debt of $17.5 million as of Q1 2023, which was up 10000.0% from $15.3 million recorded in Q4 2022.
  • Healthequity's 5-year Short term Debt high stood at $78.1 million for Q3 2021, and its period low was $6.6 million during Q4 2021.
  • Moreover, its 5-year median value for Short term Debt was $35.2 million (2019), whereas its average is $36.4 million.
  • As far as peak fluctuations go, Healthequity's Short term Debt crashed by 8949.92% in 2021, and later surged by 13332.32% in 2022.
  • Healthequity's Short term Debt (Quarter) stood at $31.2 million in 2019, then surged by 100.0% to $62.5 million in 2020, then tumbled by 89.5% to $6.6 million in 2021, then soared by 133.32% to $15.3 million in 2022, then rose by 14.28% to $17.5 million in 2023.
  • Its Short term Debt stands at $17.5 million for Q1 2023, versus $15.3 million for Q4 2022 and $13.1 million for Q3 2022.